Literature DB >> 16241937

Mathematical and biological models of blood coagulation.

T Orfeo1, K G Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16241937      PMCID： PMC1410194          DOI： 10.1111/j.1538-7836.2005.01592.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  7 in total

1.  The thrombogram: monitoring thrombin generation in platelet-rich plasma.

Authors:  H C Hemker; P L Giesen; M Ramjee; R Wagenvoord; S Béguin
Journal:  Thromb Haemost       Date:  2000-04       Impact factor: 5.249

2.  Blood coagulation at the site of microvascular injury: effects of low-dose aspirin.

Authors:  A Undas; K Brummel; J Musial; K G Mann; A Szczeklik
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

3.  During coagulation, thrombin generation shifts from chemical to diffusional control.

Authors:  H C Hemker; E DE Smedt; P W Hemker
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

4.  "Normal" thrombin generation.

Authors:  S Butenas; C van't Veer; K G Mann
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

5.  The plasma hemostatic proteome: thrombin generation in healthy individuals.

Authors:  K Brummel-Ziedins; C Y Vossen; F R Rosendaal; K Umezaki; K G Mann
Journal:  J Thromb Haemost       Date:  2005-07       Impact factor: 5.824

6.  A model for the stoichiometric regulation of blood coagulation.

Authors:  Matthew F Hockin; Kenneth C Jones; Stephen J Everse; Kenneth G Mann
Journal:  J Biol Chem       Date:  2002-03-13       Impact factor: 5.157

7.  Thrombin functions during tissue factor-induced blood coagulation.

Authors:  Kathleen E Brummel; Sara G Paradis; Saulius Butenas; Kenneth G Mann
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113
  7 in total
  2 in total

1.  Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation.

Authors:  Rolf Burghaus; Katrin Coboeken; Thomas Gaub; Lars Kuepfer; Anke Sensse; Hans-Ulrich Siegmund; Wolfgang Weiss; Wolfgang Mueck; Joerg Lippert
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

2.  Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor.

Authors:  Rolf Burghaus; Katrin Coboeken; Thomas Gaub; Christoph Niederalt; Anke Sensse; Hans-Ulrich Siegmund; Wolfgang Weiss; Wolfgang Mueck; Takahiko Tanigawa; Jörg Lippert
Journal:  Front Physiol       Date:  2014-11-07       Impact factor: 4.566
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.